Completed OBSERVATIONAL NCT00635258

Administration of GnRH Antagonist to Oocyte Donation Recipients (GnRH-Ovodon)

Administration of GnRH Antagonist to Oocyte Donation Recipients During Endometrial Preparation.

Sponsor: Centro Ginecologia y Obstetricia.

Conditions Embryo Implantation Pregnancy

Interventions GnRH antagonist (Orgalutran®) triptorelin (Decapeptyl®, Ipsen Pharma, Barcelona, Spain)

Updated 6 times since 2017 Last updated: Mar 6, 2008 Started: Jan 31, 2004 Primary completion: Dec 31, 2007 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00635258, this observational or N/A phase trial focuses on Embryo Implantation and Pregnancy and remains completed. Sponsored by Centro Ginecologia y Obstetricia., it has been updated 6 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centro Ginecologia y Obstetricia.
University of Valencia

Data source: Centro Ginecologia y Obstetricia.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valencia, Spain